← All trials
NCT04876131
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2021
- Primary completion
- May 31, 2028
- Completion date
- May 31, 2028
- First posted
- May 6, 2021
- Last posted
- Jun 10, 2021
- Enrollment
- 452
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Murdoch UniversityLead sponsor
- Murdoch UniversityOverall official - principal investigator
- University of MelbourneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.